Royal London Asset Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
Royal London Asset Management's EXAS Position: Q2 2025 in Review
Royal London Asset Management sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 8,343 shares — an estimated $361K sold.
Royal London Asset Management first reported a position in EXAS in Q3 2019 and held it in 21 quarters. The position peaked at $7.75M in Q2 2021. 559 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.
- Royal London Asset Management reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
- Royal London Asset Management sold 8,343 Exact Sciences shares in Q2 2025, an estimated $361K.
- Royal London Asset Management first reported a position in Exact Sciences in Q3 2019 and held it in 21 quarters.
- Royal London Asset Management's Exact Sciences position peaked at $7.75M in Q2 2021.
- 559 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.
Based on Royal London Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.